Nu Skin Enterprises, Inc. (NYSE:NUS) had its price objective boosted by stock analysts at Bank of America Corporation from $53.00 to $57.00 in a note issued to investors on Monday. The brokerage currently has an “underperform” rating on the stock. Bank of America Corporation’s price target indicates a potential downside of 9.05% from the stock’s previous close.

Other analysts have also recently issued research reports about the stock. Zacks Investment Research cut shares of Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research report on Saturday, June 24th. Deutsche Bank AG raised their price objective on shares of Nu Skin Enterprises from $63.00 to $66.00 and gave the company a “buy” rating in a research report on Wednesday, June 21st. Sidoti cut shares of Nu Skin Enterprises from a “buy” rating to a “neutral” rating and set a $59.00 price objective on the stock. in a research report on Wednesday, April 26th. Pivotal Research restated a “buy” rating and set a $65.00 price objective on shares of Nu Skin Enterprises in a research report on Thursday, May 4th. Finally, ValuEngine upgraded shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Friday, June 2nd. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and four have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $61.38.

Nu Skin Enterprises (NYSE:NUS) traded up 0.84% on Monday, hitting $62.67. The stock had a trading volume of 424,138 shares. Nu Skin Enterprises has a 12-month low of $45.00 and a 12-month high of $66.04. The company has a market capitalization of $3.31 billion, a PE ratio of 20.80 and a beta of 1.32. The company has a 50 day moving average of $58.20 and a 200 day moving average of $53.72.

Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings data on Wednesday, May 3rd. The company reported $0.51 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.50 by $0.01. The firm had revenue of $499.10 million for the quarter, compared to analysts’ expectations of $493.65 million. Nu Skin Enterprises had a net margin of 7.48% and a return on equity of 23.45%. The business’s quarterly revenue was up 5.8% on a year-over-year basis. During the same quarter last year, the company posted $0.42 EPS. On average, equities analysts expect that Nu Skin Enterprises will post $3.12 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Wednesday, June 14th. Investors of record on Friday, May 26th were given a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a yield of 2.30%. The ex-dividend date was Wednesday, May 24th. Nu Skin Enterprises’s payout ratio is presently 48.48%.

COPYRIGHT VIOLATION NOTICE: This news story was posted by Daily Political and is the property of of Daily Political. If you are viewing this news story on another domain, it was copied illegally and republished in violation of U.S. and international copyright and trademark laws. The correct version of this news story can be read at https://www.dailypolitical.com/2017/07/10/nu-skin-enterprises-inc-nus-given-new-57-00-price-target-at-bank-of-america-corporation.html.

In related news, General Counsel D Matthew Dorny sold 8,000 shares of Nu Skin Enterprises stock in a transaction on Monday, June 5th. The shares were sold at an average price of $56.39, for a total value of $451,120.00. Following the transaction, the general counsel now owns 52,730 shares in the company, valued at approximately $2,973,444.70. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In the last quarter, insiders sold 24,250 shares of company stock worth $1,436,770. 5.20% of the stock is owned by corporate insiders.

A number of institutional investors have recently modified their holdings of the company. Russell Investments Group Ltd. purchased a new position in Nu Skin Enterprises during the fourth quarter worth about $3,124,000. State Street Corp boosted its position in Nu Skin Enterprises by 2.4% in the fourth quarter. State Street Corp now owns 802,056 shares of the company’s stock worth $38,321,000 after buying an additional 18,471 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in Nu Skin Enterprises by 4.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 947,226 shares of the company’s stock worth $45,260,000 after buying an additional 39,926 shares during the last quarter. Renaissance Technologies LLC boosted its position in Nu Skin Enterprises by 269.9% in the fourth quarter. Renaissance Technologies LLC now owns 200,100 shares of the company’s stock worth $9,561,000 after buying an additional 146,000 shares during the last quarter. Finally, New York State Teachers Retirement System boosted its position in Nu Skin Enterprises by 2.1% in the fourth quarter. New York State Teachers Retirement System now owns 4,900 shares of the company’s stock worth $234,000 after buying an additional 100 shares during the last quarter. Institutional investors own 85.54% of the company’s stock.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Analyst Recommendations for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.